Nano-X Imaging Ltd. (NASDAQ: NNOX) Advances Its Mission to Expand Access to Medical Imaging

• Nanox is working to make advanced medical imaging more accessible through digital 3D tomosynthesis technology designed to enhance visualization beyond conventional X-rays.
• Its Nanox.ARC platform combines imaging hardware with cloud-based infrastructure, while the company’s broader services support image interpretation and clinical workflows.
• By connecting image acquisition with remote radiology expertise and AI-powered analysis, Nanox aims to support healthcare providers’ imaging and interpretation workflows more efficiently.

Access to medical imaging remains an important consideration for healthcare systems, particularly in underserved regions where equipment, infrastructure and trained personnel may be limited. While conventional X-rays play an essential role in diagnostic care, their two-dimensional images can make certain anatomical details more difficult to distinguish when structures overlap. In some healthcare settings, rising imaging volumes and radiologist workforce constraints can also place pressure on diagnostic services. These challenges underscore the importance of developing imaging technologies that can complement existing diagnostic approaches while integrating into established clinical environments and workflows.

Nano-X Imaging (NASDAQ: NNOX) is approaching that problem from a different direction. Nanox is assembling an integrated platform intended to extend medical imaging into outpatient facilities, clinics and other settings where conventional advanced imaging infrastructure may not be available.

At the center of this effort is Nanox.ARC, an FDA-cleared multi-source digital tomosynthesis system that incorporates the company’s proprietary digital X-ray source technology. The system is designed to produce 3D tomosynthesis images for its cleared intended uses and to support imaging in a range of clinical settings.

That matters because limited imaging access isn’t purely a technology issue. It’s equally an economic one, driven by the high cost of equipment, the facility infrastructure required, and the specialized staff needed both to run the systems and to interpret the results.

Nanox presents the Nanox.ARC as one element of its wider initiative to bring advanced imaging into a broader range of healthcare settings. In the United States, the system is presently cleared only for adjunctive use alongside conventional radiography in adult patients for designated indications. In Europe, Nanox.ARC has obtained CE Mark certification, allowing commercialization, in accordance with the relevant country-specific regulations. 

Nanox continues to advance its imaging technology and develop additional capabilities aimed at expanding clinical applications and improving imaging workflows, subject to applicable regulatory requirements. However, expanding access to medical imaging goes beyond the imaging system itself. Healthcare providers also need solutions that support image management, interpretation, and access to radiology expertise.

Nanox addresses these needs through its broader imaging ecosystem. Nanox.CLOUD, the company’s cloud-based software platform, supports the management and storage of imaging data generated by Nanox devices. Through its subsidiary USARAD, Nanox also provides teleradiology services, while Nanox.MARKETPLACE offers remote access to radiology and cardiology experts. Together, these solutions support the company’s vision of providing an end-to-end imaging solution, extending from image acquisition to interpretation.

The company’s AI business adds another layer to this approach. Nanox.AI extends the value of routine medical imaging by leveraging AI to uncover additional clinical insights from CT scans already performed for other purposes. Its solutions help clinicians identify potentially overlooked imaging findings associated with chronic conditions, including cardiovascular disease, osteoporosis, and fatty liver disease. By transforming existing imaging data into actionable information for clinicians, Nanox.AI aims to support more informed clinical assessment and patient management.

Ultimately, Nanox’s strategy focuses on delivering an integrated, end-to-end medical imaging solution that connects image acquisition, management, interpretation, and AI-based analysis. By combining its digital tomosynthesis technology, cloud-based software, teleradiology services, and AI solutions, the company aims to improve clinical efficiency, expand access to medical imaging, and support earlier detection of chronic conditions. This integrated approach reflects Nanox’s broader vision of driving the transition toward more accessible, preventive healthcare.

For more information, visit the company’s website at https://www.nanox.vision.

NOTE TO INVESTORS: The latest news and updates relating to NNOX are available in the company’s newsroom at https://ibn.fm/NNOX

About AINewsWire

AINewsWire (“AINW”) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

AINewsWire
Austin, Texas
www.AINewsWire.com
512.354.7000 Office
Editor@AINewsWire.com

AINewsWire is powered by IBN